Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.

The Journal of clinical endocrinology and metabolism - 27 Sept 2021

Poma Anello Marcello, Viola David, Macerola Elisabetta, Proietti Agnese, Molinaro Eleonora, De Vietro Dario, Elisei Rossella, Materazzi Gabriele, Miccoli Paolo, Basolo Fulvio, Ugolini Clara

Abstract excerpt

CONTEXT: Recent diagnostic criteria updates of the tall cell variant of papillary thyroid carcinoma (TCPTC) by the World Health Organization (WHO) have determined the inclusion of tumors with 30% to 49% of tall cells. However, the impact of tall cell percentage on papillary thyroid carcinoma (PTC) patients' prognosis is still debated. OBJECTIVE: We aimed to evaluate whether tall cell percentage affects patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Proto-Oncogene Proteins B-raf

Share to Survival Rate

Share to Telomerase

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 34061965
DOI: 10.1210/clinem/dgab388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.PMID 34061965Read ↗

Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.Semantic proximity Read ↗

Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.Semantic proximity Read ↗

Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma.Semantic proximity Read ↗

Papillary thyroid carcinoma tall cell variant.Semantic proximity Read ↗

Classic Papillary Thyroid Carcinoma with Tall Cell Features and Tall Cell Variant Have Similar Clinicopathologic FeaturesSemantic proximity Read ↗

A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.Semantic proximity Read ↗

Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk DiseaseSemantic proximity Read ↗

Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.Semantic proximity Read ↗

Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.Semantic proximity Read ↗

TERT promoter-mutated thyroid carcinomas: prognostic and histologic insights according to the WHO 2022 classification.Semantic proximity Read ↗

[Clinicopathological features and molecular characteristics of tall cell and hobnail variants of papillary thyroid carcinoma].Semantic proximity Read ↗

Papillary thyroid carcinoma and its variants in fine needle aspiration smears. A cytomorphologic study with special reference to tall cell variant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.